Holen Sie sich die Stockscreener-App
7.36
9.80%
-0.80
Vorhandelsmarkt:
7.20
-0.16
-2.17%
Schlusskurs vom Vortag:
$8.16
Offen:
$6.45
24-Stunden-Volumen:
300.16K
Relative Volume:
2.58
Marktkapitalisierung:
$86.75M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-73.52M
KGV:
-11.15
EPS:
-0.66
Netto-Cashflow:
$-100.45M
1W Leistung:
+2.51%
1M Leistung:
+35.29%
6M Leistung:
+28.00%
1J Leistung:
-18.40%
1-Tages-Spanne:
$6.18
$7.74
1-Wochen-Bereich:
$6.18
$8.82
52-Wochen-Spanne:
$3.61
$8.9545
Precision Biosciences Inc Stock (DTIL) Company Profile
Firmenname
Precision Biosciences Inc
Sektor
Branche
Telefon
919-314-5512
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Vergleichen Sie DTIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
7.36 | 96.18M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Eingeleitet | Guggenheim | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-09 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Fortgesetzt | BTIG Research | Buy |
| 2020-04-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Stifel | Buy |
| 2020-02-25 | Eingeleitet | William Blair | Outperform |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-22 | Eingeleitet | Barclays | Overweight |
| 2019-04-22 | Eingeleitet | Goldman | Buy |
| 2019-04-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-22 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
Precision BioSciences: Q3 Earnings Snapshot - CT Insider
Detecting price anomalies in Precision BioSciences Inc. with AIMarket Performance Summary & Low Drawdown Trading Techniques - newser.com
Precision BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Multi asset correlation models including Precision BioSciences Inc.Earnings Performance Report & Technical Pattern Alert System - newser.com
Is Precision BioSciences Inc. stock a defensive play in 20252025 Support & Resistance & High Yield Stock Recommendations - newser.com
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - TradingView
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
How Precision BioSciences Inc. stock trades during market volatilityQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Has Precision BioSciences Inc. found a price floorJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - TipRanks
Can Precision BioSciences Inc. stock resist market sell offsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryDollar Strength & Entry and Exit Point Strategies - newser.com
Imugene to Issue 19.5 Million Shares, Pay $3 Million in Cash to Precision Biosciences as Milestone Payment Under Licensing Agreement - MarketScreener
Will Precision BioSciences Inc. outperform the marketTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidate2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Imugene to explore discussions with FDA, triggering Precision BioSciences milestone - Proactive financial news
Real time breakdown of Precision BioSciences Inc. stock performanceMarket Performance Report & Reliable Breakout Forecasts - newser.com
Why millennials buy Precision BioSciences Inc. (PBS0) stockMarket Activity Recap & Weekly Momentum Picks - newser.com
Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance
A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st
Is Precision BioSciences Inc. stock positioned well for digital economyQuarterly Profit Summary & Verified Entry Point Signals - newser.com
Earnings visualization tools for Precision BioSciences Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Update & AI Driven Stock Reports - newser.com
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):